CNTA insider transactions
Centessa Pharmaceuticals plc (CNTA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
CNTA insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Centessa Pharmaceuticals plc, latest first. Follow anyone to get their next filing.
- Medicxi Ventures Management (Jersey) Ltd10% owner
- Index Ventures Life Vi (jersey) L.P.10% owner
- Tia L BushChief Technology & Quality Ofc-$4.76M
- Iqbal J HussainChief Legal Officer-$4.32M
- John J CrowleyChief Financial Officer, since June 2024
- Karen M. AndersonChief People Officer, since November 2022-$11.2M
- Raphael DeferiereChief Accounting Officer, since May 2025
- Francesco De RubertisDirector
- Arjun GoyalDirector+$5.87M
- Stephen KanesChief Medical Officer, since January 2025
- Mario Alberto AccardiChief Executive Officer, Director, since June 2025-$1.44M
- Mary Lynne HedleyDirector
- Zbar Brett I WDirector
- Carol StuckleyDirector
- Mathias HukkelhovenDirector, since July 2022
- Gregory M WeinhoffChief Business Officer-$5.84M
- Samarth KulkarniDirector
- Saurabh SahaChief Executive Officer, Director+$95K-$15.1M
- David M ChaoChief Administrative Officer-$150K
- Harris RotmanSVP Regulatory Affairs, since June 2023-$270K
- David J GraingerChief Innovation Officer+$249K-$20.7K
- GAP (Bermuda) L.P.Director, 10% owner
- Antoine YverOfficer-$1.03M
- Thomas TemplemanOfficer-$17.8K
- Javad ShahidiOfficer, since March 2022-$24.3K
- Marella ThorellOfficer
Recent Form 3, 4, and 5 filings for CNTA
- Large owner Medicxi Ventures Management (Jersey) Ltd sold 19,963,157 units of Ordinary Shares (SEC Form 4) to cover taxes4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Large owner Index Ventures Life Vi (Jersey) L.P. sold 9,961,789 units of Ordinary Shares (SEC Form 4) (withholding obligation)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief People Officer Anderson Karen M. returned 62,085 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4) to cover taxes4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Technology & Quality Ofc Bush Tia L returned 147,954 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding obligation)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Director Goyal Arjun returned 462,585 units of Ordinary Shares to the company (SEC Form 4) (tax liability)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Executive Officer Accardi Mario Alberto returned 243,282 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding obligation)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Legal Officer Hussain Iqbal J returned 123,145 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4) (tax withholding)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Financial Officer Crowley John J returned 45,000 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4) to satisfy tax liability4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Accounting Officer Deferiere Raphael returned 11,000 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4) to cover taxes4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Director De Rubertis Francesco returned 19,963,157 units of Ordinary Shares to the company (SEC Form 4) to satisfy withholding tax4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Business Officer Weinhoff Gregory M returned 65,925 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4) to satisfy withholding tax4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Medical Officer Kanes Stephen returned 120,000 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding obligation)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Director Hedley Mary Lynne (tax withholding)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Director Kulkarni Samarth to cover withholding tax4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Director Hukkelhoven Mathias (tax withholding)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Director Stuckley Carol (withholding tax)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Director Zbar Brett I W (for tax liability)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Executive Officer Accardi Mario Alberto covered exercise/tax liability with 604 units of Ordinary Shares, decreasing direct ownership by 0.25% to 243,282 units (SEC Form 4) to cover withholding tax4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Anderson Karen M.4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Weinhoff Gregory M4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Anderson Karen M.4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Amendment: Chief People Officer Anderson Karen M. exercised 109,398 units of Ordinary Shares at a strike of $3.99 and sold $3,150,673 worth of Ordinary Shares (120,029 units at $26.25), decreasing direct ownership by 15% to 62,085 units (SEC Form 4)4/A - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief People Officer Anderson Karen M. exercised 109,398 units of Ordinary Shares at a strike of $4.01 and sold $3,150,673 worth of Ordinary Shares (120,029 units at $26.25), decreasing direct ownership by 15% to 62,085 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Business Officer Weinhoff Gregory M sold $1,927,131 worth of Ordinary Shares (73,196 units at $26.33), decreasing direct ownership by 53% to 65,925 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Medical Officer Kanes Stephen was granted 120,000 units of Ordinary Shares (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Financial Officer Crowley John J was granted 45,000 units of Ordinary Shares (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Accounting Officer Deferiere Raphael was granted 11,000 units of Ordinary Shares (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Legal Officer Hussain Iqbal J sold $1,004,918 worth of Ordinary Shares (39,961 units at $25.15), covered exercise/tax liability with 7,780 units of Ordinary Shares and was granted 60,000 units of Ordinary Shares, increasing direct ownership by 12% to 117,645 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Business Officer Weinhoff Gregory M covered exercise/tax liability with 14,158 units of Ordinary Shares and was granted 31,000 units of Ordinary Shares, increasing direct ownership by 14% to 139,121 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Executive Officer Accardi Mario Alberto was granted 68,000 units of Ordinary Shares and covered exercise/tax liability with 2,915 units of Ordinary Shares, increasing direct ownership by 36% to 243,886 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief People Officer Anderson Karen M. was granted 29,000 units of Ordinary Shares and covered exercise/tax liability with 10,606 units of Ordinary Shares, increasing direct ownership by 34% to 72,716 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Technology & Quality Ofc Bush Tia L covered exercise/tax liability with 8,549 units of Ordinary Shares and was granted 35,000 units of Ordinary Shares, increasing direct ownership by 22% to 147,954 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- President, Orexin Program Accardi Mario Alberto sold $288,289 worth of Ordinary Shares (10,000 units at $28.83), decreasing direct ownership by 5% to 178,801 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- President, Orexin Program Accardi Mario Alberto exercised 5,000 units of Ordinary Shares at a strike of $9.53 and sold $300,000 worth of Ordinary Shares (10,000 units at $30.00), decreasing direct ownership by 3% to 188,801 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- General Counsel Hussain Iqbal J exercised 6,000 units of Ordinary Shares at a strike of $5.84 and sold $165,835 worth of Ordinary Shares (6,000 units at $27.64) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Technology & Quality Ofc Bush Tia L exercised 40,000 units of Ordinary Shares at a strike of $9.42 and sold $1,120,000 worth of Ordinary Shares (40,000 units at $28.00) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Technology & Quality Ofc Bush Tia L exercised 40,000 units of Ordinary Shares at a strike of $9.42 and sold $1,040,000 worth of Ordinary Shares (40,000 units at $26.00) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- President, Orexin Program Accardi Mario Alberto covered exercise/tax liability with 593 units of Ordinary Shares, decreasing direct ownership by 0.31% to 193,801 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- President, Orexin Program Accardi Mario Alberto exercised 5,000 units of Ordinary Shares at a strike of $8.01 and sold $200,000 worth of Ordinary Shares (8,000 units at $25.00), decreasing direct ownership by 2% to 194,394 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- General Counsel Hussain Iqbal J exercised 6,000 units of Ordinary Shares at a strike of $5.84 and sold $134,439 worth of Ordinary Shares (6,000 units at $22.41) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Technology & Quality Ofc Bush Tia L exercised 35,000 units of Ordinary Shares at a strike of $9.42 and sold $840,000 worth of Ordinary Shares (35,000 units at $24.00) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- President, Orexin Program Accardi Mario Alberto sold $174,846 worth of Ordinary Shares (8,172 units at $21.40), decreasing direct ownership by 4% to 197,394 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- General Counsel Hussain Iqbal J exercised 6,000 units of Ordinary Shares at a strike of $5.84 and sold $131,101 worth of Ordinary Shares (6,000 units at $21.85) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Technology & Quality Ofc Bush Tia L exercised 49,792 units of Ordinary Shares at a strike of $8.72 and sold $1,045,840 worth of Ordinary Shares (49,792 units at $21.00) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- General Counsel Hussain Iqbal J exercised 40,000 units of Ordinary Shares at a strike of $5.84 and sold $840,102 worth of Ordinary Shares (40,000 units at $21.00) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- President, Orexin Program Accardi Mario Alberto exercised 5,000 units of Ordinary Shares at a strike of $8.01 and sold $140,000 worth of Ordinary Shares (7,000 units at $20.00), decreasing direct ownership by 0.96% to 205,566 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- General Counsel Hussain Iqbal J exercised 6,000 units of Ordinary Shares at a strike of $5.84 and sold $103,380 worth of Ordinary Shares (6,000 units at $17.23) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- President, Orexin Program Accardi Mario Alberto covered exercise/tax liability with 597 units of Ordinary Shares, decreasing direct ownership by 0.29% to 207,566 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- President, Orexin Program Accardi Mario Alberto sold $126,751 worth of Ordinary Shares (8,322 units at $15.23), decreasing direct ownership by 4% to 208,163 units (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Business Officer Weinhoff Gregory M exercised 10,000 units of Ordinary Shares at a strike of $3.85 and sold $155,598 worth of Ordinary Shares (10,000 units at $15.56) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Executive Officer Saha Saurabh exercised 55,000 units of Ordinary Shares at a strike of $3.85 and sold $875,600 worth of Ordinary Shares (55,000 units at $15.92) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- General Counsel Hussain Iqbal J exercised 6,000 units of Ordinary Shares at a strike of $5.84 and sold $89,567 worth of Ordinary Shares (6,000 units at $14.93) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- Chief Business Officer Weinhoff Gregory M exercised 10,000 units of Ordinary Shares at a strike of $3.85 and sold $138,642 worth of Ordinary Shares (10,000 units at $13.86) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- General Counsel Hussain Iqbal J exercised 12,000 units of Ordinary Shares at a strike of $5.84 and sold $168,218 worth of Ordinary Shares (12,000 units at $14.02) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- President, Orexin Program Accardi Mario Alberto exercised 15,000 units of Ordinary Shares at a strike of $3.85 and sold $210,000 worth of Ordinary Shares (15,000 units at $14.00) (SEC Form 4)4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Director Goyal Arjun4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Director Hedley Mary Lynne4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Director Hukkelhoven Mathias4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Director Kulkarni Samarth4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
- SEC Form 4 filed by Director Stuckley Carol4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)